Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Neoplasms of the CNS

Free Subscription 06.07.2026 1 Acta Neuropathol 3 AJNR Am J Neuroradiol 9 BMC Cancer 6 BMC Neurol 1 Br J Neurosurg 1 Cancer Res 11 Childs Nerv Syst 1 Clin Cancer Res 1 Int J Radiat Oncol Biol Phys 2 J Clin Oncol 38 J Neurooncol 10 J Neurosurg 3 Neuro Oncol 1 Neurology 2 Neuroradiology 1 Neurosurgery 1 Oncogene 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. ALTENDORF L, Althammer A, Roy R, Hack K, et al
   Molecular changes during AT/RT progression associated with epithelial-mesenchymal transition and extracellular matrix changes.
   Acta Neuropathol. 2026;152:1.
   PubMed         Abstract available
   
   

   
   AJNR Am J Neuroradiol

2. KAZIMUDDIN HF, Pathakamuri A, Yi J, Soldatos A, et al
   Gadolinium-Enhanced Portable Ultra-Low-Field MRI for Evaluating Various Intracranial Pathologies.
   AJNR Am J Neuroradiol. 2026;47:1927-1932.
   PubMed         Abstract available
   
   
3. LIU S, Zhang X, Fang Q, Zhao M, et al
   High-Resolution MRI Using Artificial Intelligence-Assisted Acceleration and Radial Dynamic Contrast Enhancement for Improved Detection of Pituitary Microadenomas in Cushing Disease.
   AJNR Am J Neuroradiol. 2026;47:1879-1886.
   PubMed         Abstract available
   
   
4. STRAUSS WE, Fu R, Szidonya LK, Muir L, et al
   Superiority of Ferumoxytol MRI over Precontrast Imaging in Patients with Malignant Brain Lesions.
   AJNR Am J Neuroradiol. 2026;47:1855-1862.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. HE Y, Yu J, Huang M, Lu P, et al
   Single-cell transcriptomics reveals MAFB-driven macrophage reprogramming and immune divergence in recurrent glioblastoma.
   BMC Cancer. 2026 Jun 29. doi: 10.1186/s12885-026-16321.
   PubMed         Abstract available
   
   
6. TONG N, Qu Y, Guo K, Li M, et al
   Prognostic value of Neutrophil-to-Lymphocyte Ratio (NLR) in patients with Leptomeningeal Metastasis (LM) from solid tumors.
   BMC Cancer. 2026;26:715.
   PubMed         Abstract available
   
   
7. WANG Z, Cao Y, Wang Q, Wang L, et al
   Real-world evidence for first-line intrathecal pemetrexed in leptomeningeal metastases from solid tumors: a retrospective cohort study.
   BMC Cancer. 2026;26:651.
   PubMed         Abstract available
   
   
8. LIU S, Li Y, Shen Y, Mao Q, et al
   Redefining M1: a novel three-tiered classification stratifies prognosis in metastatic breast cancer.
   BMC Cancer. 2026 Mar 19. doi: 10.1186/s12885-026-15861.
   PubMed        
   
   
9. GUPTA T, Dasgupta A, Goswami S, Chatterjee A, et al
   Memantine to preserve memory and neurocognition following craniospinal irradiation (MEMENTO): a phase 3 randomized controlled trial.
   BMC Cancer. 2026;26:365.
   PubMed         Abstract available
   
   
10. OJALA E, Kuitunen H, Ronka A, Pellonpera E, et al
    Educational and regional differences in population-based incidence and survival of primary central nervous system lymphoma in Finland.
    BMC Cancer. 2026 Jan 17. doi: 10.1186/s12885-026-15556.
    PubMed        
    
    
11. GAO B, Yao Z, Wu L, Shao K, et al
    Necessity of daily IGRT? Dosimetric study of beam position offsets at central double-beam junction in pediatric craniospinal irradiation.
    BMC Cancer. 2025;26:4.
    PubMed         Abstract available
    
    
12. LIU P, Peng Y, Sun Y, Hu S, et al
    Assessing the prognostic value of SIL1 in pan-cancer cohorts and its practical application as a biomarker in glioma practice.
    BMC Cancer. 2026 Jun 29. doi: 10.1186/s12885-026-16241.
    PubMed         Abstract available
    
    
13. DUAN X, Niu W, Li X, Li Z, et al
    Radiomics-based intratumoral heterogeneity subtypes in IDH wild-type glioblastoma with pathomic and transcriptomic association analyses: a multicenter study.
    BMC Cancer. 2026 Jul 3. doi: 10.1186/s12885-026-16417.
    PubMed         Abstract available
    
    

    
    BMC Neurol

14. BAI D, Wang Z
    Neurosyphilis with simultaneous brain and spinal cord involvement mimicking intracranial tumors: a case report.
    BMC Neurol. 2026;26:277.
    PubMed         Abstract available
    
    
15. HAN Y, Qiu M, Wu J, Cheng L, et al
    Amelanotic primary thalamic melanoma: a case report.
    BMC Neurol. 2026;26:294.
    PubMed         Abstract available
    
    
16. WANG J, Fan Y, Zhang W
    A 57-year-old male with diffuse astrocytoma in the lateral ventricle: case report.
    BMC Neurol. 2026;26:288.
    PubMed         Abstract available
    
    
17. TANG H, Zhu Z, Huang S, Cai M, et al
    Clinical predictors of postoperative cerebrospinal fluid leakage following endoscopic endonasal surgery for pituitary neuroendocrine tumors: a retrospective cohort study.
    BMC Neurol. 2026;26:237.
    PubMed         Abstract available
    
    
18. LI A, Gao P, Tian W, Zhou M, et al
    Granular cell tumors of the neurohypophysis with atypical imaging features: a case report and literature review.
    BMC Neurol. 2026 Feb 25. doi: 10.1186/s12883-026-04709.
    PubMed        
    
    
19. ZHANG M, Liu X, Cheng S, Ruan Y, et al
    A case report: primary central nervous system lymphoma misdiagnosed as neuromyelitis optica.
    BMC Neurol. 2026 Feb 16. doi: 10.1186/s12883-026-04711.
    PubMed        
    
    

    
    Br J Neurosurg

20. SAKAJI K, Shimoda Y, Kanamori M, Osawa SI, et al
    Preoperative visualization and intraoperative functional assessment of a long medullary artery in glioblastoma surgery using ultra-high-resolution intra-arterial Computed tomography angiography: an illustrative case.
    Br J Neurosurg. 2026 Jul 3:1-8. doi: 10.1080/02688697.2026.2694473.
    PubMed         Abstract available
    
    

    
    Cancer Res

21. LEE E, Kang Y
    MIF-CD74 Signaling Defines a Brain-Specific Immune Vulnerability in Metastasis and Neurologic Disease.
    Cancer Res. 2026;86:3103-3105.
    PubMed         Abstract available
    
    

    
    Childs Nerv Syst

22. CHEN L, Li S, Wang L, Li H, et al
    Fulminant extraneural metastases in MYC-amplified Group 3 medulloblastoma: a pediatric case report.
    Childs Nerv Syst. 2026;42:284.
    PubMed         Abstract available
    
    
23. YAO X, Yang L, Shen M, Wei Y, et al
    Astroblastoma-like tumor with an EWSR1::BEND2 fusion in the fourth ventricle: a case report and narrative review.
    Childs Nerv Syst. 2026;42:283.
    PubMed         Abstract available
    
    
24. KEUSCH DS, Choi JH, Lopes C, Smith ER, et al
    Operative management of pediatric radiation-induced cavernous malformations: insights from a single-center cohort.
    Childs Nerv Syst. 2026;42:269.
    PubMed         Abstract available
    
    
25. PIMPLODKAR M, Deopujari C, Mohanty C, Karmarkar V, et al
    Spinal intradural Ewing's sarcoma metastasising to the brain.
    Childs Nerv Syst. 2026;42:267.
    PubMed         Abstract available
    
    
26. SABET K, Lovell H, Fonseca A
    Pediatric medulloblastoma.
    Childs Nerv Syst. 2026;42:271.
    PubMed         Abstract available
    
    
27. CAPPELLANO AM, Dassi N, Gamba FT, Zecchin VG, et al
    High-dose chemotherapy with autologous stem cell rescue in children under 5 years of age with central nervous system embryonal tumors: results from a prospective cohort in an upper-middle-income country.
    Childs Nerv Syst. 2026;42:274.
    PubMed         Abstract available
    
    
28. YANG Z, Yue Y, Wu F, Hu X, et al
    A case-control study of MRI features in pediatric atypical teratoid rhabdoid tumor and medulloblastoma.
    Childs Nerv Syst. 2026;42:276.
    PubMed         Abstract available
    
    
29. CHANG H, Wang F, Wang Y, Wang X, et al
    Pediatric intraspinal space-occupying lesions: navigating diagnostic pitfalls, surgical complexity, and neurological outcomes in 27 cases.
    Childs Nerv Syst. 2026;42:277.
    PubMed         Abstract available
    
    
30. LU W, Jin T, Tang T, He J, et al
    Neuroendoscopic treatment of a rapidly enlarging choroidal fissure cyst: a case report and literature review.
    Childs Nerv Syst. 2026;42:278.
    PubMed         Abstract available
    
    
31. GIUSEPPE M, Domenico C, Giulia M, Nicola O, et al
    Single-center longitudinal experience with MRgLITT in pediatric neurosurgery: technical evolution, expanding indications, and advanced MRI-driven planning.
    Childs Nerv Syst. 2026;42:280.
    PubMed         Abstract available
    
    
32. EELKMAN ROODA OHJ, Sie M, Plasschaert SLA, Kranendonk MEG, et al
    The emerging role of intraoperative nanopore sequencing on the neurosurgical strategy in paediatric embryonal brain tumours.
    Childs Nerv Syst. 2026;42:282.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

33. LINDSAY HB, Billups CA, Kocak M, Alban TJ, et al
    Pediatric Brain Tumor Consortium phase 1 study of CD40 agonist sotigalimab in pediatric and young adult patients with recurrent CNS tumors and newly-diagnosed DIPG.
    Clin Cancer Res. 2026 Jun 30. doi: 10.1158/1078-0432.CCR-26-0655.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

34. LINKOWSKI L, Messing I, Berger M, Hollawell C, et al
    Hypofractionated Proton Reirradiation for Recurrent Glioblastoma: Clinical and Dosimetric Outcomes from a Large Single Institution Series.
    Int J Radiat Oncol Biol Phys. 2026 Jul 2:S0360-3016(26)03919.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

35. BAUMERT BG, Hegi ME, van den Bent MJ, von Deimling A, et al
    Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).
    J Clin Oncol. 2026 Jul 2:JCO2502735. doi: 10.1200/JCO-25-02735.
    PubMed         Abstract available
    
    
36. MARCISCANO AE, Shih HA
    Biology Over Monotherapy: Mature Results From European Organisation For Research and Treatment of Cancer 22033-26033 Reaffirm Molecular Stratification, Not Treatment Sequence, Defines Prognosis in Low-Grade Glioma.
    J Clin Oncol. 2026 Jul 2:JCO2600771. doi: 10.1200/JCO-26-00771.
    PubMed        
    
    

    
    J Neurooncol

37. ZHU Y, Qiu Z, Zhu L, Lu C, et al
    Prognostic factors and quality of life in non-small cell lung cancer with leptomeningeal metastasis: a dichotomous pattern based on parenchymal involvement.
    J Neurooncol. 2025;176:114.
    PubMed         Abstract available
    
    
38. LUO S, Liu R, Li P, Tu H, et al
    Combined stereotactic radiotherapy and immunotherapy improves survival in driver-gene-negative NSCLC patients with brain oligo-metastases: a multicenter real-world study.
    J Neurooncol. 2025;176:127.
    PubMed         Abstract available
    
    
39. DHO YS, Shin SH, Gwak HS, Yoo H, et al
    Re-evaluation of cerebrospinal fluid cytology for diagnosis of leptomeningeal metastasis based on radiological features, patient symptoms/signs, and clinical follow-up.
    J Neurooncol. 2026;176:149.
    PubMed         Abstract available
    
    
40. HUANG H, Gao F, Quan R, Zhou W, et al
    Transcriptome sequencing analysis revealed the molecular mechanism of BNCT inhibiting the growth of U87 subcutaneous tumor.
    J Neurooncol. 2026;176:153.
    PubMed         Abstract available
    
    
41. UMEZAWA Y, Yamamoto M, Tanaka K, Yoshifuji K, et al
    Induction chemotherapy with methotrexate, nimustine, and procarbazine for primary CNS lymphoma in the elderly: a retrospective evaluation of safety and efficacy.
    J Neurooncol. 2026;176:173.
    PubMed         Abstract available
    
    
42. KITE T, Mckenna A, Wegner RE, Herbst J, et al
    Stereotactic radiosurgery for pineal gland metastases: results from the international radiosurgery research foundation.
    J Neurooncol. 2026;176:188.
    PubMed         Abstract available
    
    
43. KIDWELL RL, Trippett J, Aghi MK
    Molecular biology of pituitary neuroendocrine tumors.
    J Neurooncol. 2026;176:197.
    PubMed         Abstract available
    
    
44. JOHNSON KJ, Brown DS, Johnston KJ
    SEER-Medicaid and SEER-Medicare data for neuro-oncology research.
    J Neurooncol. 2026;176:205.
    PubMed         Abstract available
    
    
45. HOOKS RE, Yadav N, Mondia MWL, Mantziaris G, et al
    Belzutifan-induced tumor regression in sporadic hemangioblastoma: a case report and literature review.
    J Neurooncol. 2026;176:213.
    PubMed         Abstract available
    
    
46. GUHA A, Gawde J, Mahajan K, Bagal B, et al
    Is looking at the tip of the iceberg sinking our ship? A longitudinal cohort study on the patterns of evolution on treatment of non-enhancing FLAIR lesions in primary CNS lymphoma.
    J Neurooncol. 2026;177:7.
    PubMed         Abstract available
    
    
47. FALCAO V, Rego LHRM, Rodrigues PB, de Moraes FCA, et al
    Hormone therapy and the risk of central nervous system tumors in women: a systematic review and meta-analysis.
    J Neurooncol. 2026;177:13.
    PubMed         Abstract available
    
    
48. ELGEHINY A, Fan AE, Frost M, He J, et al
    Clinical and translational progress in oncolytic virotherapy for pediatric CNS tumors.
    J Neurooncol. 2026;177:17.
    PubMed         Abstract available
    
    
49. ZHANG C, Yin C, Xie J, Hou Z, et al
    Trends in global, regional and national burden of brain and CNS cancers, 1990-2021 and predictions to 2036: analysis based on the global burden of disease study 2021.
    J Neurooncol. 2026;177:18.
    PubMed         Abstract available
    
    
50. BEN-SHOSHAN A, Heymann S, Asprilla J, Kelmer P, et al
    Upfront stereotactic radiosurgery for large posterior fossa metastases: a multicenter evaluation of clinical outcomes.
    J Neurooncol. 2026;177:25.
    PubMed         Abstract available
    
    
51. HIMIC V, Vargas-George S, Knott MV, Govindarajan V, et al
    Non-diagnostic stereotactic intracranial biopsies: a 15-year institutional experience.
    J Neurooncol. 2026;177:116.
    PubMed         Abstract available
    
    
52. MASSIMINO M, Carrabba G, Vennarini S, Pecori E, et al
    Surgery and radiotherapy strategies at first relapse of pediatric intracranial ependymoma: an Italian retrospective study integrating molecular subgrouping.
    J Neurooncol. 2026;177:124.
    PubMed         Abstract available
    
    
53. KHAZANCHI R, Govind S, Jain R, Vignolles-Jeong J, et al
    Unsupervised clustering analysis reveals distinct postoperative cortisol trajectories following pituitary adenoma resection in Cushing's disease.
    J Neurooncol. 2026;177:132.
    PubMed         Abstract available
    
    
54. GARCIA-MILAN V, Bauluz Olmedo L, Marcos S, Lau R, et al
    A label-free nanoplasmonic biosensor for intraoperative discrimination of tumor margins in brain metastases surgery.
    J Neurooncol. 2026;178:81.
    PubMed         Abstract available
    
    
55. SHAH R, Jain S, Haldar N, Holt LA, et al
    Fractionated stereotactic radiotherapy (fSRT) for symptomatic WHO grade 1 cavernous sinus meningiomas: long-term local control, clinical response, and toxicity outcomes.
    J Neurooncol. 2026;178:83.
    PubMed         Abstract available
    
    
56. WU WY, Numan Hellquist B, Melin B, Bjorkblom B, et al
    Intratumoral serotonin and antidepressants in glioblastoma patients: narrowing the uncertainties.
    J Neurooncol. 2026;178:84.
    PubMed         Abstract available
    
    
57. LIN J, Tang W, Li K, Chen Z, et al
    Clinical, surgical, and molecular characteristics and outcomes of adult patients with diffuse midline glioma, H3 K27-altered, treated with surgical resection.
    J Neurooncol. 2026;178:85.
    PubMed         Abstract available
    
    
58. SHARMA A, Agrawal D, Natanasabapathi G, Saha S, et al
    Real-time confocal imaging for evaluation of dose-dependent effects of gamma knife radiosurgery on U87 glioblastoma cell line.
    J Neurooncol. 2026;178:86.
    PubMed         Abstract available
    
    
59. ALMEIDA ND, Sinha S, Fang M, Cheruvu H, et al
    Gamma knife radiosurgery for renal cell carcinoma brain metastases across systemic therapy eras: survival, intracranial failure, and lesion-level predictors.
    J Neurooncol. 2026;178:87.
    PubMed         Abstract available
    
    
60. SHARPE MA, Baskin AM, Teh BS, Butler EB, et al
    Optimizing the Stupp protocol for treatment of glioblastoma: eliminating age bias, enhancing treatment timing, use of stereotactically-guided sequential boost, and dexamethasone dosing.
    J Neurooncol. 2026;178:88.
    PubMed         Abstract available
    
    
61. ABU-ARJA MH, Rajabi Z, McGlynn MC, Ghebrelul RT, et al
    Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors.
    J Neurooncol. 2026;177:111.
    PubMed         Abstract available
    
    
62. GHOCHE MT, Gecici NN, Miki K, Yuan F, et al
    Predictors of diagnostic yield and surgical safety in stereotactic brain biopsy.
    J Neurooncol. 2026;177:112.
    PubMed         Abstract available
    
    
63. YANG M, Zhou D, Fan J, Qi X, et al
    Low-grade neuroepithelial tumor with FGFR1::TACC1 fusion: a clinicopathologic analysis of seven cases.
    J Neurooncol. 2026;177:110.
    PubMed         Abstract available
    
    
64. KIM T, Kim SK, Chung CK, Park CK, et al
    Long-term radiological progression after resection of dysembryoplastic neuroepithelial tumors: patterns and prognostic factors.
    J Neurooncol. 2026;177:94.
    PubMed         Abstract available
    
    
65. GONZALEZ-AGUILAR A, Jimenez-Quintero A, Diaz-Alba A, Macias-Arriaga G, et al
    Multiple presentations: a single pathology, primary central nervous system lymphoma (PCNSL). A multicenter study.
    J Neurooncol. 2026;177:93.
    PubMed         Abstract available
    
    
66. SHRIVASTAVA S, Szewczyk C, Grelewicz Z, Schelt JV, et al
    Cesium-131 brachytherapy for central nervous system salvage therapy.
    J Neurooncol. 2026;177:80.
    PubMed         Abstract available
    
    
67. WANG X, Wen H, Xie Y, Xu T, et al
    Salvage dacomitinib plus intraventricular pemetrexed for leptomeningeal metastasis after failure of third?generation EGFR?TKIs in EGFR?mutant NSCLC: an ambispective cohort study.
    J Neurooncol. 2026;177:76.
    PubMed         Abstract available
    
    
68. WEE CW, Park JW, Suh CO, Lim DH, et al
    Improved tumor control with adjuvant radiotherapy in patients with central neurocytoma: a multicenter study.
    J Neurooncol. 2026;177:68.
    PubMed         Abstract available
    
    
69. LIU J, Han Q, Wu W, Wang H, et al
    [(18)F]FET-PET in dissecting low-grade oligodendrogliomas.
    J Neurooncol. 2026;177:65.
    PubMed         Abstract available
    
    
70. OZONO I, Yamasaki F, Onishi S, Yonezawa U, et al
    T2-FLAIR mismatch sign in nonenhancing astrocytoma, IDH-mutant: impact of tumor area on diagnostic sensitivity.
    J Neurooncol. 2026;177:64.
    PubMed         Abstract available
    
    
71. SONG R, Dapash M, Jamshidi P, Gondi V, et al
    Survival and function in elderly patients with GBM: the role of surgical resection with contemporary multimodal therapy.
    J Neurooncol. 2026;177:62.
    PubMed         Abstract available
    
    
72. PULSIPHER AM, Khattar G, Gotway MB, Grill MF, et al
    Pneumocystis jirovecii pneumonia in patients with CNS tumors receiving dexamethasone: clinical outcomes and prophylaxis gaps.
    J Neurooncol. 2026;177:51.
    PubMed         Abstract available
    
    
73. KOHANBASH G, Ryall S, Gary SE, Hoffman LM, et al
    PTPN11-related Noonan syndrome predisposes to multifocal low-grade CNS tumors harboring FGFR1 variants.
    J Neurooncol. 2026;177:31.
    PubMed         Abstract available
    
    
74. MAYEN T, Morelle M, Zouaoui S, Kallel M, et al
    Adolescents and young adults with predominantly low grade primary central nervous system tumors: patient reported socioeconomic outcomes and health-related quality of life ten years after diagnosis.
    J Neurooncol. 2026;177:32.
    PubMed         Abstract available
    
    

    
    J Neurosurg

75. CATALINO MP, Suki D, Ballester L, Andersen CR, et al
    Extent of resection as an independent predictor of survival for patients with glioblastoma as defined by the new WHO 2021 classification.
    J Neurosurg. 2026 Jul 3:1-11. doi: 10.3171/2026.1.JNS25467.
    PubMed         Abstract available
    
    
76. MARTINEZ-PEREZ R, Cepeda S, Ahmad M, Hemmer S, et al
    Development and internal validation of the Meningioma Functional Outcome Risk and Counseling Estimator 6 score, a point-based prognostic tool for predicting 6-week functional independence after intracranial meningioma resection.
    J Neurosurg. 2026 Jul 3:1-10. doi: 10.3171/2026.1.JNS252588.
    PubMed         Abstract available
    
    
77. LIU KG, Gomez D, Shah I, Cote DJ, et al
    Postoperative days 1 and 2 morning cortisol levels as predictors of long-term secondary adrenal insufficiency following pituitary adenoma surgery.
    J Neurosurg. 2026;145:59-67.
    PubMed         Abstract available
    
    
78. D'AVELLA E, Berardinelli J, Zoli M, Zenga F, et al
    Complications in endoscopic endonasal surgery for pituitary neuroendocrine tumors: an Italian multicenter study.
    J Neurosurg. 2026;145:68-78.
    PubMed         Abstract available
    
    
79. AGOSTINI L, Rychen J, Vigo V, Xu Y, et al
    Inferolateral trunk: anatomical study, surgical relevance, and technical nuances in lateral transcavernous endoscopic endonasal surgery.
    J Neurosurg. 2026;145:79-91.
    PubMed         Abstract available
    
    
80. SHUKLA PD, Peeran Z, Osorio RC, Rajidi A, et al
    Resection versus fenestration for Rathke's cleft cysts: a propensity score-matched analysis of long-term outcomes.
    J Neurosurg. 2026;145:92-102.
    PubMed         Abstract available
    
    
81. ABI FARAJ C, Moss NS, Leung CH, Gule-Monroe MK, et al
    Reevaluating routine imaging: clinical utility of postoperative CT after stereotactic brain biopsy.
    J Neurosurg. 2026 Apr 10:1-16. doi: 10.3171/2025.11.JNS251196.
    PubMed         Abstract available
    
    
82. SASAKI Y, Bando H, Kanzawa M, Fukuhara N, et al
    Molecular markers of Rathke's cleft cysts and their clinical correlates: insights from experimental and human analyses.
    J Neurosurg. 2026;145:103-111.
    PubMed         Abstract available
    
    
83. FILIZ M, Yilmaz R, Tee T, Pachchigar P, et al
    AI assessment of surgical technical skill adaptation across depth levels in simulated tumor resection: a case series study.
    J Neurosurg. 2026;145:263-273.
    PubMed         Abstract available
    
    
84. MANSOURT A, Cuny T, Norri N, Choucha A, et al
    Partial or full preservation of the pituitary stalk in craniopharyngioma surgery: improving endocrinological outcomes without an increased risk of recurrence.
    J Neurosurg. 2026 Jul 3:1-10. doi: 10.3171/2026.1.JNS251501.
    PubMed         Abstract available
    
    

    
    Neuro Oncol

85. SBERGIO SG, Liang H, Chen L, Canty L, et al
    Tumor-Targeted pan-RAS Inhibition as a Novel Biologic Therapy for Diffuse Midline Glioma.
    Neuro Oncol. 2026 Jun 29:noag148. doi: 10.1093.
    PubMed         Abstract available
    
    
86. HASHEMI E, Akshaya RL, Wang L, Bergland S, et al
    MAPK-driven glioma progression and reprogramming of the tumor-associated immune response.
    Neuro Oncol. 2026 Jun 30:noag147. doi: 10.1093.
    PubMed         Abstract available
    
    
87. ZHANG L, Wang H, Huang G, Qi X, et al
    The clinical and molecular landscape of thalamic glioma.
    Neuro Oncol. 2026 Jun 30:noag146. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Neurology

88. BENARROCH E
    What is the Relevance of Neuron-Tumor Interactions in Malignant CNS Tumors?
    Neurology. 2026;107:e218291.
    PubMed         Abstract available
    
    

    
    Neuroradiology

89. MSHERGHI A, Glue-Monroe M, W Eldaya R, Pirhoushiaran M, et al
    Preliminary assessment of an MRI-based grading system for leptomeningeal disease: an exploratory prognostic framework.
    Neuroradiology. 2026 Jan 26. doi: 10.1007/s00234-026-03904.
    PubMed         Abstract available
    
    
90. LI Y, Liu G, Zhang J, Wang M, et al
    Comparative study of radiomics features between ASL and DSC perfusion-weighted imaging in distinguishing radiation-induced brain injury from glioma recurrence.
    Neuroradiology. 2026 Jun 29. doi: 10.1007/s00234-026-04086.
    PubMed         Abstract available
    
    

    
    Neurosurgery

91. SHEEHAN J, Kondziolka D
    Neurosurgeons Are Essential in the Interdisciplinary Care of Patients With Brain Metastasis.
    Neurosurgery. 2026;99:253-255.
    PubMed        
    
    

    
    Oncogene

92. HU B, Guo P, Bar-Joseph I, Imanishi Y, et al
    Correction: Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
    Oncogene. 2026 Jul 2. doi: 10.1038/s41388-026-03882.
    PubMed        
    
    

    
    PLoS One

93. UROOJ S, Napte K, Alsubaie N
    Deep learning based two-way feature depiction model for brain tumor detection.
    PLoS One. 2026;21:e0344291.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Neoplasms of the CNS is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum